Free Trial

Whitehawk Therapeutics (WHWK) Earnings Date, Estimates & Call Transcripts

Whitehawk Therapeutics logo
$4.21 +0.05 (+1.20%)
Closing price 04:00 PM Eastern
Extended Trading
$4.20 0.00 (-0.12%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Whitehawk Therapeutics Earnings Summary

Whitehawk Therapeutics issued Q4 2025 earnings on March 12, 2026, reporting an EPS of -$0.34, which beat the consensus estimate of -$0.55 by $0.21. With a trailing EPS of $0.47 and a P/E Ratio of 8.96, Whitehawk Therapeutics' earnings are expected to decrease next year, from ($1.43) to ($1.50) per share.

Q4 2025 Earnings Resources

Consensus EPS
(Mar. 12)
-$0.55
Actual EPS
(Mar. 12)
-$0.34 Beat By $0.21
Get Whitehawk Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Whitehawk Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

WHWK Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Whitehawk Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.27-$0.27-$0.27
Q2 20261-$0.28-$0.28-$0.28
Q3 20261-$0.29-$0.29-$0.29
Q4 20261-$0.30-$0.30-$0.30

Whitehawk Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/12/2026Q4 2025-$0.55-$0.34+$0.21-$0.34--
11/6/2025Q3 2025-$0.51-$0.26+$0.25-$0.26--
8/7/2025Q2 2025$0.49-$0.76 -$1.25-$0.76$100.00M-

Data powered by Fiscal.ai.

Whitehawk Therapeutics Earnings - Frequently Asked Questions

Whitehawk Therapeutics (NASDAQ:WHWK) last announced its quarterly earning data on Thursday, March 12, 2026. Learn more on WHWK's earnings history.

In the previous quarter, Whitehawk Therapeutics (NASDAQ:WHWK) reported ($0.34) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.55) by $0.21. Learn more on analysts' earnings estimate vs. WHWK's actual earnings.

Whitehawk Therapeutics (NASDAQ:WHWK) has a recorded annual revenue of $7.14 million.

Whitehawk Therapeutics (NASDAQ:WHWK) has a recorded net income of -$20.60 million. WHWK has generated $0.47 earnings per share over the last four quarters.

Whitehawk Therapeutics (NASDAQ:WHWK) has a trailing price-to-earnings ratio of 8.95.

Whitehawk Therapeutics' earnings are expected to decrease from ($1.43) per share to ($1.50) per share in the next year.


This page (NASDAQ:WHWK) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners